Literature DB >> 18298515

AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.

Takeshi Kato1, Takeshi Yamashita, Akiko Sekiguchi, Takayuki Tsuneda, Kouichi Sagara, Masayuki Takamura, Shuichi Kaneko, Tadanori Aizawa, Long-Tai Fu.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is one of the independent risk factors for atrial fibrillation (AF). Our previous study has indicated that DM causes atrial structural remodeling with intraatrial conduction disturbances. We tested the hypothesis that the advanced glycation end products (AGEs) and the receptor for AGE (RAGE), which have been implicated in diabetic complications, are responsible for the atrial structural remodeling. METHODS AND
RESULTS: Diabetes was induced by streptozotocin (65 mg/kg i.p.) in 8-week-old female Sprague-Dawley rats. When 24 weeks old, their atria were subjected to histology, Western blotting, and immunohistochemistry. The HbA(1c) value of induced-DM rats was significantly higher than that of control rats. Histological and immunohistochemical examinations revealed that the atria of diabetic rats showed remarkable structural changes characterized by diffuse interstitial fibrosis with abundant expressions of RAGE and connective tissue growth factor (CTGF), which findings were also confirmed by Western blotting analysis. This diabetes-induced atrial fibrosis was remarkably prevented by administration of an inhibitor of AGEs formation, OPB-9195, along with reduction of CTGF expression.
CONCLUSIONS: DM promoted atrial structural remodeling via the activation of the AGEs-RAGE system with upregulating CTGF. The inhibition of AGEs formation could be a novel upstream therapeutic approach for diabetes-related atrial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298515     DOI: 10.1111/j.1540-8167.2007.01037.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  40 in total

1.  Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

Authors:  Omid Fatemi; Eugene Yuriditsky; Costas Tsioufis; Demetrios Tsachris; Timothy Morgan; Jan Basile; Thomas Bigger; William Cushman; David Goff; Elsayed Z Soliman; Abraham Thomas; Vasilios Papademetriou
Journal:  Am J Cardiol       Date:  2014-07-30       Impact factor: 2.778

2.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

3.  Elevated glycated hemoglobin levels may increase the risk of atrial fibrillation in patients with diabetes mellitus.

Authors:  Yu-Fan Yang; Wen-Qing Zhu; Kuan Cheng; Qing-Xing Chen; Ye Xu; Yang Pang; Gui-Jian Liu; Jun-Bo Ge
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

5.  Hyperoxia-induced cardiotoxicity and ventricular remodeling in type-II diabetes mice.

Authors:  Jennifer Leigh Rodgers; Eva Samal; Subhra Mohapatra; Siva Kumar Panguluri
Journal:  Heart Vessels       Date:  2017-12-05       Impact factor: 2.037

6.  Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats.

Authors:  Pengmin Chen; Jingbo Zhao; Hans Gregersen
Journal:  Dig Dis Sci       Date:  2011-11-06       Impact factor: 3.199

Review 7.  Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.

Authors:  Rajeev Pathak; Dennis H Lau; Rajiv Mahajan; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 8.  Atrial Fibrillation and Metabolic Syndrome: Understanding the Connection.

Authors:  Prabhat Kumar; Anil K Gehi
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 9.  Recent advances in the molecular pathophysiology of atrial fibrillation.

Authors:  Reza Wakili; Niels Voigt; Stefan Kääb; Dobromir Dobrev; Stanley Nattel
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

10.  Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.

Authors:  Iuliia Polina; Hailey J Jansen; Tiesong Li; Motahareh Moghtadaei; Loryn J Bohne; Yingjie Liu; Pooja Krishnaswamy; Emmanuel E Egom; Darrell D Belke; Sara A Rafferty; Martin Ezeani; Anne M Gillis; Robert A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.